Abstract | OBJECTIVE: DESIGN: Retrospective case-control study. PARTICIPANTS: METHODS: The total numbers of patients and injections were determined from a review of billing code and practice management records. Endophthalmitis cases were determined from billing records and from an infection log. All cases of endophthalmitis were confirmed with chart review. A 28-month period when topical antibiotics were prescribed after intravitreal injection was compared with a 9-month period when topical antibiotics were not prescribed. Patients treated during an 8-month transition period were excluded to allow for the conversion of antibiotic prescription practices. MAIN OUTCOME MEASURES: Incidence of endophthalmitis, visual acuity outcomes, and microbial spectrum. RESULTS: During the study period, a total of 117 171 intravitreal injections were performed (57 654 injections during the topical antibiotic period, 24 617 during the transition period, and 34 900 during the no- antibiotic period), with a total of 44 cases of suspected endophthalmitis (0.038%; 1 in 2663 injections), 17 of which showed culture-positive results (0.015%; 1 in 6892 injections). During the 28-month topical antibiotic period, there were 28 cases of suspected endophthalmitis (0.049%; 1 in 2059 injections), 10 of which showed culture-positive results (0.017%; 1 in 5765 injections). During the 9-month no- antibiotic period, there were 11 cases of suspected endophthalmitis (0.032%; 1 in 3173 injections), 4 of which showed culture-positive results (0.011%; 1 in 8725 injections). Topical antibiotic use was associated with a trend toward increased risk of suspected endophthalmitis (odds ratio [OR], 1.54; 95% confidence interval [CI], 0.77-3.10) and culture-positive endophthalmitis (OR, 1.51; 95% CI, 0.47-4.83). CONCLUSIONS:
|
Authors | Philip Storey, Michael Dollin, John Pitcher, Sahitya Reddy, Joseph Vojtko, James Vander, Jason Hsu, Sunir J Garg, Post-Injection Endophthalmitis Study Team |
Journal | Ophthalmology
(Ophthalmology)
Vol. 121
Issue 1
Pg. 283-289
(Jan 2014)
ISSN: 1549-4713 [Electronic] United States |
PMID | 24144453
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Angiogenesis Inhibitors
- Anti-Bacterial Agents
- Ophthalmic Solutions
- Vancomycin
- Amikacin
- Ceftazidime
|
Topics |
- Administration, Topical
- Aged
- Amikacin
(therapeutic use)
- Angiogenesis Inhibitors
(therapeutic use)
- Anti-Bacterial Agents
(therapeutic use)
- Antibiotic Prophylaxis
- Bacteria
(isolation & purification)
- Case-Control Studies
- Ceftazidime
(therapeutic use)
- Endophthalmitis
(epidemiology, microbiology, prevention & control)
- Eye Infections, Bacterial
(epidemiology, microbiology, prevention & control)
- Female
- Humans
- Incidence
- Intravitreal Injections
- Male
- Middle Aged
- Ophthalmic Solutions
- Retinal Diseases
(drug therapy)
- Retrospective Studies
- Vancomycin
(therapeutic use)
- Visual Acuity
- Vitreous Body
(microbiology)
|